Navigation Links
Troubled waters: New device brings flexibility, precision to contamination measurement
Date:11/8/2011

Lake ApopkaFlorida's third largestwas once a haven for migratory birds, vacationers and fishermen. Today it is a toxic broth of chemicals and ranks among America's more disturbing Superfund sites.

Here, Rolf Halden and his colleagues from the Biodesign Institute at Arizona State Universityand collaborator Nancy Denslow at the University of Florida, Gainesville, are testing a new device, designed to measure contaminants with unprecedented precision, accuracy and sensitivity. In addition to detailed analyses of sediments, the team will evaluate the health effects of five specific compounds on two species of marine organism. The new project will also assess the effectiveness of remediation efforts currently being used to clean up the contaminated site.

Halden, associate director of the Swette Center for Environmental Biotechnology and his team have recently received a three-year, $830K grant from the National Institute of Environmental Health Sciences (NIEHS). Their efforts are expected to provide stakeholders at many of the nation's Superfund sites with a novel analytical tool to gauge the threat to public health posed by contaminated sediments before, during and after cleanup efforts.

The instrument being used for these studies is known as the in situ sampling/bioavailability determination tool or IS2Ba patent-pending device that can simultaneously measure contaminant levels in bulk water and pore water (the fluid occupying spaces between sediment particles).

Halden says that conceptually the sampling instrument is simple, but emphasizes that IS2B nevertheless will facilitate analyses with uncanny resolution: "Once perfected, the device will enable the determination of the fraction of chemicals that actually are available for uptake by aquatic organisms; this knowledge is important because it determines the body burden in, for example, fish harvested for human consumption."

When IS2B is in use, half of its tu
'/>"/>

Contact: Joe Caspermeyer
joseph.caspermeyer@asu.edu
Arizona State University
Source:Eurekalert  

Page: 1 2 3 4

Related biology news :

1. Troubled waters: Low Apalachicola River flow may hurt gulf fisheries
2. In troubled economic times, BioSquare 2009 successfully serves as business and innovation starter
3. Manufacturing microscale medical devices for faster tissue engineering
4. New device measures viscosity of ketchup and cosmetics
5. BioCrossroads Invests in Medical Device Company Developing Revolutionary Absorbable Stent
6. DigitalPersona Goes Mobile with New U.are.U 5100 Fingerprint Sensors for Battery-Powered Mobile ID Devices
7. FDA grant launches Atlanta Pediatric Device Consortium
8. NHTSA Awards Takata-TruTouch $2.25M to Advance Worlds First Touch-based In-Vehicle Alcohol Detection Device
9. Mobile Devices Pose New Security Risks for Patients; Five Experts Share Insights on mHealth
10. Wearable device that vibrates fingertip could improve ones sense of touch
11. Watermark ink device identifies unknown liquids instantly
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Troubled waters: New device brings flexibility, precision to contamination measurement
(Date:8/21/2014)... involves the pancreas digesting itself resulting in severe abdominal ... UK around 20,000 patients are diagnosed with the disease ... and treatment is restricted to intravenous fluid and nutritional ... of Life Sciences, who led the research, said "The ... gall stones and excessive alcohol intake combined with a ...
(Date:8/20/2014)... SALT LAKE CITY Researchers at Huntsman Cancer Institute (HCI) ... mutated forms of the gene that encodes BCR-ABL, the ... (CML). According to the American Cancer Society, nearly 6,000 ... , Drugs already in use, called tyrosine kinase inhibitors ... disease. They do not cure CML but control it ...
(Date:8/20/2014)... Scientists from the University of Tbingen, Arizona State University, ... and Public Health Institute (Swiss TPH) isolated Mycobacterium ... at least 1000 years old. The pathogen is a ... only occasionally causes disease in humans today. These researchers ... the Peruvian coast. "The link to sea lions was ...
Breaking Biology News(10 mins):Insulin offers new hope for the treatment of acute pancreatitis 2Blueprint for next generation of chronic myeloid leukemia treatment 2
... second most common cause of childhood blindness in the ... earlier than or at 28 weeks gestational age. The ... the retina of the eye. ROP risk increases with ... Brigham and Women,s Hospital (BWH) suggests that the antioxidant, ...
... young researchers were named Pew Scholars in the Biomedical ... join a prestigious community that includes Nobel Prize winners, ... Research Award. "During these challenging budgetary ... harder for scientists to obtain, we are proud to ...
... heavy rain, the lid of Nepenthes gracilis ... shelter on its underside directly into the fluid-filled pitcher, ... Wednesday 13 June, in the journal PLoS ONE ... a source of nutrients, enabling them to colonise nutrient-poor ...
Cached Biology News:Antioxidant shown to reduce blindness risk in extremely premature babies 222 of America's most promising scientists selected as Pew Biomedical Scholars 222 of America's most promising scientists selected as Pew Biomedical Scholars 3Pitcher plant uses rain drops to capture prey 2
(Date:8/21/2014)... MO (PRWEB) August 21, 2014 ... service biopharmaceutical contract development and manufacturing organization (CMO) ... Progenics Pharmaceuticals, Inc., an oncology company focused on ... treating cancer, to manufacture the anti-prostate specific membrane ... ADC product candidate. Under the agreement the ...
(Date:8/20/2014)... N.C. , Aug. 20, 2014 ... research services located in Raleigh, NC ... Bradford Evans as Vice President of Administration. ... Brad will oversee all corporate processes, including their ... joining Clintrax Global, Brad worked as an HR ...
(Date:8/20/2014)... in measuring vibrational motion of a single molecule with ... of a single molecule differs from the behaviour of ... at the University of California, Irvine, where post-doctoral researcher ... a visiting fellow under professor Vartkess A. Apkarian, whose ... lead by Professor Eric O. Potma. The results of ...
(Date:8/20/2014)... BURLINGTON, Mass. , Aug. 20, 2014  Decision Resources Group ... , Russia , India ... approximately $1.6 billion in 2013, roughly equal to the size of ... forward, however, the BRIC market will experience much faster growth as ... the aging population. Other key findings from Decision Resources ...
Breaking Biology Technology:Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3Clintrax Global, Inc. Announces Addition to Executive Team 2Seeing a molecule breathe 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 2BRIC Vascular Access Device Market Valued at $1.6 Billion in 2013, Similar to the U.S. Market 3
... and LEXINGTON, Massachusetts, August 25, 2011 Shire ... specialty biopharmaceutical company, today announced that the U.S. Food and ... (icatibant injection) for treatment of acute attacks of hereditary ... "Until now, HAE patients faced challenges gaining rapid ...
... CBI, a division of Advanstar Communications, is pleased ... Tufts Center for the Study of Drug Development and ... the keynote speaker at their Pharma/Bio Forum on Preclinical ... at the Hyatt Harborside in Boston, MA. Dr. Kaitin ...
... school science teachers will explore the nanotechnology field at ... build interest in science and engineering. ... of Engineering a $429,000 grant to fund "Innovations in ... Starting next summer, selected middle and high school ...
Cached Biology Technology:FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE) 2FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE) 3FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE) 4FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE) 5FDA Approves Shire's FIRAZYR® (icatibant injection) for Acute Attacks of Hereditary Angioedema (HAE) 6Dr. Ken Kaitin, Tufts CSDD, Keynotes Preclinical Conference 2University of Houston receives NSF grant for high school teachers program 2
5,6 Carboxyfluorescein is conjugated to BSA (bovine serum albumin) protein through amide bonds....
MOUSE ANTI BOVINE WC1:FITC Immunogen: Bovine lymphocytes...
B.D. Hames and D.M. Glover (1996) • This issue covers T-Cell antigen receptor genes; T-Lymphocyte signal transduction; B-Cell activation antibody engineering and the complement system and other ...
...
Biology Products: